Gene Query: AMOTL2

Dataset Description Geneva Score
RNA-seq in transgenic cells 114.45
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 114.11
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 87.52
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 78.83
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 78.51
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 78.51
Silencing SPIB in attached and floating state of H1703 lung cancer cells 78.2
Uridylation by TUT4 and TUT7 marks mRNA for degradation 76.31
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 68.74
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 67.89
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 61.06
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 58.02
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 57.67
RNA-seq analyisis of PUM2 knockout cells 57.62
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 56.68
PGE2 mediated gene expression changes in human cervical stromal cells 53.42
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 53.2
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 53.2
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 52.03
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 51.67
Crizotinib v. DMSO in SW480 cells 51.36
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 51.23
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 49.98
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 49.59
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 49.31
Genome wide expression change by RNF168 knocking down in MCF-7 cells 46.59
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 43.75
DIGIT regulates endoderm differentiation of human embryonic stem cells 43.44
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 42.34
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 40.86
Identification of Nrf2 regulated genes by RNA sequencing 40.62
Nrf2 regulated genes in A549 cells 40.62
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 40.18
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 39.79
Effect of BMP inhibition or stimulation of primary human keratinocytes 39.49
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 39.49
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 39.37
Lineage specific differentiation is influenced by state of human pluripotency 39.37
Spliceosomal disruption of the non-canonical BAF complex in cancer 39.35
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 39.23
An RNA-centric dissection of host complexes controlling flavivirus infection 39.23
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 38.57
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 38.51
Tracking of dCas9-methyltransferase footprints 38.51
RNA sequencing analysis of human embryonic stem cells and axial progenitors 38.2
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 37.7
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 37.25
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 36.8
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 36.8
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 36.77
Human embryonic stem cells in E8 and AKIT culture medium 36.77
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 36.67
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 36.52
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 36.19
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 36.01
RNA-seq analysis of BAP1-depleted uveal melanoma cells 35.64
Redifferentiation of expanded human islet β cells by inhibition of ARX 35.54
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 35.48
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 35.3
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 34.65
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 34.41
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 34.32
Mechanistic Model-Guided Study of Embryonic Morphogenesis 34.27
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 33.49
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 33.43
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 33.43
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 32.84
Statins modulate endothelial transcriptional profile by inhibiting EZH2 32.12
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 32.04
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 31.84
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 31.82
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 31.28
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 31.11
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 31.11
Toxoplasma gondii infection of human retinal pigment epithelial cells 31.07
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 31.05
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 30.97
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 30.95
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 30.95
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 30.95
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 30.47
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 30.35
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 30.35
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 30.03
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 30.03
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 29.85
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 29.72
Genome-wide analysis of the Integrator complex 28.8
Genome-wide analysis of the Integrator complex (HTS) 28.8
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 28.74
RNA sequencing of GlyH-101-treated MCF-7 cell line 28.67
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 28.45
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 28.22
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 28.14
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 27.8
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 27.8
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 27.74
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 27.7
Downregulation of LATS kinases alters p53 to promote cell migration 27.55
MEIS1 regulates hematopoiesis in hPSCs 27.06
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 27.03
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 26.84
Effect of Influenza virus infection on lncRNA expression in A549 cells 26.82
Tyrosine Kinase Inhibitor Cardiotoxicity 26.81
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 26.81
SUV420H2 knockdown in PANC-1 26.79
Effect of drugs on transcriptomic profiles 26.78
A transcriptome-wide divergence in protein translation scales with LIN28B expression 26.3
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 26.23
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 26.23
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 25.94
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 25.57
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 25.41
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 25.19
Transcriptome analysis of BAP1 knockout and restoration 25.19
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 25.17
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 25.08
RNA-seq of tumor cells following angiopellosis extravasation 25.08
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 24.92
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 24.91
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 24.91
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 24.55
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 24.33
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 24.29
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 24.07
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 24.01
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 23.94
BET bromodomain inhibition 23.94
SF3B1 Degron knockdown RNA-seq 23.93
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 23.9
Hepatitis C virus functionally sequesters miR-122 23.9
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 23.84
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 23.84
Gene expression analysis of dengue-infected cells 23.8
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 23.64
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 23.64
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 23.5
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 23.45
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 23.45
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 23.43
The MEF2B Regulatory Network 23.2
The MEF2B Regulatory Network - RNA-seq data 23.2
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 23.04
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 22.93
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 22.88
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 22.88
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 22.82
Generation of trichogenic adipose-derived stem cells by expression of three factors 22.81
Lipid degradation promotes prostate cancer cell survival 22.62
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 22.52
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 22.3
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 22.28
MCF10A H-Ras RNA-Seq 22.26
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 22.26
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 22.25
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 22.08
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 21.89
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 21.88
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 21.79
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 21.57
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 21.56
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 21.56
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 21.47
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 21.47
Sensing self and nonself circular RNAs 21.41
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 21.38
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 21.36
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 21.35
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 21.34
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 21.25
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 21.24
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 20.89
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 20.68
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 20.44
RNA-seq analysis of uveal melanoma cells treated with FR900359 20.34
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 20.23
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 20.22
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 20.16
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 19.91
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 19.9
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 19.88
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 19.88
MYCL and EP400 are required for Max and MCPyV mediated gene activation 19.69
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 19.67
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 19.62
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 19.6
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 19.55
CD95/Fas ligand mRNA is toxic to cells 19.5
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 19.48
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 19.48
RNA-seq in HepG2 and IMR90 cells 19.29
Evolution of a transcriptional regulator from a transmembrane nucleoporin 19.29
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 19.24
Analysis of transcriptional regulation by Myt1 and Myt1l 19.0
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 18.89
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 18.87
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 18.8
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 18.8
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 18.68
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 18.54
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 18.44
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 18.43
Genome-wide identification of cancer-specific alternative splicing in circRNA 18.28
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 18.24
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 18.17
mRNA-Seq profiling of human developing kidney 17.84
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 17.75
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 17.64
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 17.61
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 17.61
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 17.53
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 17.46
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 17.46
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 17.27
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 17.2
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 17.2
circRNA-sequencing 17.19
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 17.05
Gene Expression Profiling of WT and KDM3A Knocked out Cell 17.05
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 17.01
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 16.94
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 16.94
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 16.94
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 16.87
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 16.83
Next Generation Sequencing of human SMA and healthy control Motor Neurons 16.67
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 16.65
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 16.63
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  16.6
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 16.58
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 16.33
A549 cell transcriptome responses to infection with H7N9 influenza virus 16.31
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 16.25
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 16.14
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 16.08
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 16.05
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 16.01
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 16.01
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 15.94
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 15.92
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 15.92
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 15.69
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 15.64
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 15.63
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 15.62
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 15.57
FOXD3 is a novel tumor suppressor in lung cancer 15.5
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 15.5
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 15.46
TGF-β promotes genomic instability after loss of RUNX3 15.41
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 15.37
Hypoxic transcriptome of SQ20B human head and neck cancer cells 15.35
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 15.27
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 15.26
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 15.07
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 15.07
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 15.07
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 15.06
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 14.98
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.96
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.96
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 14.94
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 14.87
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 14.85
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 14.85
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 14.85
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 14.8
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 14.8
Functional astrocytes differentiated from hiPSCs 14.78
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 14.67
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 14.66
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 14.66
Transcriptome profiling of Normal and Cancerous Prostate Cells 14.58
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 14.56
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 14.56
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 14.53
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 14.52
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 14.52
RNA m5C Methylation in breast cancer using MeRIP-Seq 14.5
Generation of KRAS signatures using immortalized isogenic lung cells. 14.49
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 14.47
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 14.46
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 14.24
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 14.19
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 14.11
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 14.11
14.06
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 14.04
Zika infected neural stem cells 13.96
Transcriptome analysis of Zika infected neural stem cells 13.96
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 13.9
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 13.89
Characterization of parental and rociletinib-resistant derived H1975 cell lines 13.88
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 13.78
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 13.76
IMP3 regulated gene expression in breast cancer cells 13.72
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 13.67
RNA transcriptome analysis during HSV-1 infection 13.63
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 13.63
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 13.6
RNA-seq analysis of RALD iPSCs after in vitro differentiation 13.51
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 13.49
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 13.42
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 13.42
Role of CD133 molecule in WNT response and renal repair 13.3
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 13.29
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 13.23
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 13.11
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 13.09
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 13.03
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 12.89
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 12.84
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 12.78
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 12.78
MicroRNA targetome analysis during HCMV infection 12.77
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 12.72
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 12.72
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 12.65
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 12.65
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 12.65
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 12.61
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 12.57
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 12.5
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 12.49
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 12.49
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 12.4
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 12.4
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 12.29
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 12.22
Effect of ILF3 on translation during homeostasis and the antiviral response 12.1
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 11.9
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 11.9
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 11.89
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 11.84
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 11.82
STRIPAK directs PP2A activity to promote oncogenic transformation 11.78
Modeling Familial Cancer with iPSC Approaches 11.78
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 11.77
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 11.69
Single cell transcriptome of peritoneal cells 11.54
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 11.44
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 11.2
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 11.09
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 11.03
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 10.99
Transcriptome analysis reveals differential splicing events in IPF lung tissue 10.96
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 10.96
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 10.96
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 10.93
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 10.84
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 10.82
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 10.74
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 10.73
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 10.69
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 10.52
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 10.47
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 10.46
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 10.17
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 10.12
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 10.11
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 10.06
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 10.02
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 10.02
Zika virus infection reprograms global transcription of host cells to allow sustained infection 10.02
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 9.78
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 9.78
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 9.69
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 9.69
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 9.65
m6A-dependent regulation of messenger RNA stability 9.6
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 9.59
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 9.51
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 9.46
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 9.46
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 9.45
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 9.34
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 9.32
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 9.32
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 9.32
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 9.26
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 9.19
Retinoic acid suppresses MYB in adenoid cystic carcinoma 9.17
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 9.17
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 9.11
Gene expression changes in human melanoma cell lines compared to primary melanocytes 9.09
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 8.87
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 8.85
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 8.66
4sUDRB-seq: measuring transcription elongation and initiation genomewide 8.56
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 8.53
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 8.53
Ribosomal protein RPL26 is the principal target of UFMylation 8.43
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 8.4
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 8.4
The transcriptome effect of overexpressing EZH2 in MCF7 8.31
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 8.31
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 8.17
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 8.16
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 8.07
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 8.06
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 7.96
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 7.94
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 7.91
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 7.81
SRSF1 role in cellular gene expression and splicing 7.74
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 7.63
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 7.63
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 7.48
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 7.48
Gene profiling of human adult and pediatric liver cancer cells 7.33
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 7.13
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 7.13
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 7.12
Small-molecule targeting of brachyury transcription factor addiction in chordoma 6.98
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 6.94
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 6.9
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 6.89
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 6.86
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 6.84
hESC neural differentiation 6.69
RNA-seq analysis of gene expression patterns during hESC neural differentiation 6.69
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 6.46
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 6.42
Genome-wide discovery of human splicing branchpoints 6.11
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 6.1
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 5.89
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 5.89
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 5.85
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 5.82
The circadian transcriptional landscape in primary human mammary epithelial cells 5.8
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 5.71
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 5.63
Copper Regulation of HIF-1 Transcription Activity 5.59
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 5.59
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 5.46
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 5.43
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.32
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 5.3
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 5.27
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.26
Active translatome profiling with RiboLace in MCF7 cells 5.26
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 4.66
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 4.63
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.57
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.46
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 4.4
Genome-wide discovery of human splicing branchpoints [RNAse] 4.2
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 4.19
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 4.14
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 4.05
Gene expression analysis upon mtDNA depletion 4.0
Gene expression analysis upon mtDNA depletion [RNA-seq] 4.0
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.91
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.88
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 3.83
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 3.83
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.82
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.75
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.44
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 3.3
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.21
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 3.13
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.11
CD73 knockdown effect in pancreatic cancer cell lines 3.1
FOXP2's impact on the primate transcriptome 3.05
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 2.99
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 2.93
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.91
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.91
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 2.84
Metabolism as an early predictor of DPSCs aging 2.83
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.69
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.69
RNA sequencing analysis of selumetinib-resistant CRC cells lines 2.69
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 2.58
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.89
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.89
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.85
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 1.73
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.6
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.49
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 1.34
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 1.25
TFAP2C signalling in human fibroblasts 1.2
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.13
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.11
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 0.99
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.92
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.9
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.75
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.73
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.71
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.65
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.59
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.49
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.47
Gene expression analysis in response to hypoxic pathway inhibition 0.45
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.23
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.22
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.18


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation